125 related articles for article (PubMed ID: 1532406)
1. Efficacy of intermittent dosage of 8-aminoquinolines for therapy or prophylaxis of Pneumocystis pneumonia in rats.
Queener SF; Dean RA; Bartlett MS; Milhous WK; Berman JD; Ellis WY; Smith JW
J Infect Dis; 1992 Apr; 165(4):764-8. PubMed ID: 1532406
[TBL] [Abstract][Full Text] [Related]
2. 8-Aminoquinolines from Walter Reed Army Institute for Research for treatment and prophylaxis of Pneumocystis pneumonia in rat models.
Bartlett MS; Queener SF; Tidwell RR; Milhous WK; Berman JD; Ellis WY; Smith JW
Antimicrob Agents Chemother; 1991 Feb; 35(2):277-82. PubMed ID: 2024961
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of clindamycin/primaquine versus trimethoprim/sulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia.
Ruf B; Rohde I; Pohle HD
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):207-10. PubMed ID: 2060533
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR
Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948
[TBL] [Abstract][Full Text] [Related]
5. Clindamycin/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
Kay R; DuBois RE
South Med J; 1990 Apr; 83(4):403-4. PubMed ID: 2321069
[TBL] [Abstract][Full Text] [Related]
6. Effects of 8-aminoquinolines on the ultrastructural morphology of Pneumocystis carinii.
Goheen MP; Bartlett MS; Shaw MM; Queener SF; Smith JW
Int J Exp Pathol; 1993 Aug; 74(4):379-87. PubMed ID: 8398811
[TBL] [Abstract][Full Text] [Related]
7. Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia.
Barber BA; Pegram PS; High KP
Clin Infect Dis; 1996 Oct; 23(4):718-22. PubMed ID: 8909833
[TBL] [Abstract][Full Text] [Related]
8. Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection.
Morris-Jones SD; Easterbrook PJ
J Antimicrob Chemother; 1997 Sep; 40(3):315-8. PubMed ID: 9338481
[No Abstract] [Full Text] [Related]
9. Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group.
Toma E; Thorne A; Singer J; Raboud J; Lemieux C; Trottier S; Bergeron MG; Tsoukas C; Falutz J; Lalonde R; Gaudreau C; Therrien R
Clin Infect Dis; 1998 Sep; 27(3):524-30. PubMed ID: 9770152
[TBL] [Abstract][Full Text] [Related]
10. Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind pilot trial.
Toma E; Fournier S; Dumont M; Bolduc P; Deschamps H
Clin Infect Dis; 1993 Aug; 17(2):178-84. PubMed ID: 8399863
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.).
Bartlett MS; Fishman JA; Durkin MM; Queener SF; Smith JW
Exp Parasitol; 1990 Jan; 70(1):100-6. PubMed ID: 2295322
[TBL] [Abstract][Full Text] [Related]
12. Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo.
Queener SF; Bartlett MS; Richardson JD; Durkin MM; Jay MA; Smith JW
Antimicrob Agents Chemother; 1988 Jun; 32(6):807-13. PubMed ID: 3261959
[TBL] [Abstract][Full Text] [Related]
13. Dilemmas in the prophylaxis of Pneumocystis carinii pneumonia.
Glatt AE
South Med J; 1994 Apr; 87(4):429-30. PubMed ID: 8153765
[TBL] [Abstract][Full Text] [Related]
14. Intermittent chemoprophylaxis for Pneumocystis carinii pneumonia.
Hughes WT; Smith BL
Antimicrob Agents Chemother; 1983 Aug; 24(2):300-1. PubMed ID: 6605717
[TBL] [Abstract][Full Text] [Related]
15. Inoculated mouse model of Pneumocystis carinii infection.
Bartlett MS; Queener SF; Durkin MM; Shaw MA; Smith JW
Diagn Microbiol Infect Dis; 1992 Feb; 15(2):129-34. PubMed ID: 1572137
[TBL] [Abstract][Full Text] [Related]
16. 8-aminoquinolines effective against Pneumocystis carinii in vitro and in vivo.
Queener SF; Bartlett MS; Nasr M; Smith JW
Antimicrob Agents Chemother; 1993 Oct; 37(10):2166-72. PubMed ID: 8257140
[TBL] [Abstract][Full Text] [Related]
17. Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.
Black JR; Feinberg J; Murphy RL; Fass RJ; Finkelstein D; Akil B; Safrin S; Carey JT; Stansell J; Plouffe JF
Clin Infect Dis; 1994 Jun; 18(6):905-13. PubMed ID: 8086551
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis and therapy for Pneumocystis pneumonia--where are we?
Masur H
Infect Agents Dis; 1992 Oct; 1(5):270-8. PubMed ID: 1344666
[TBL] [Abstract][Full Text] [Related]
19. Clindamycin with primaquine for Pneumocystis carinii pneumonia.
Toma E; Fournier S; Poisson M; Morisset R; Phaneuf D; Vega C
Lancet; 1989 May; 1(8646):1046-8. PubMed ID: 2566001
[TBL] [Abstract][Full Text] [Related]
20. Clindamycin-primaquine versus pentamidine for the second-line treatment of pneumocystis pneumonia.
Kim T; Kim SH; Park KH; Cho OH; Sung H; Kim MN; Choi SH; Jeong JY; Woo JH; Kim YS; Lee SO
J Infect Chemother; 2009 Oct; 15(5):343-6. PubMed ID: 19856077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
